REVOLAX SUB-Q™ is a high-viscoelastic, monophasic hyaluronic acid filler engineered for deep volumization and facial contouring. It features 100% non-animal, BDDE-cross-linked HA (24 mg/mL) and 0.3% lidocaine for a comfortable injection experience.
Key Benefits
- Maximum Lift & Structure: Highest viscosity in the REVOLAX line delivers durable support for deep folds and volume enhancement
- Natural Integration: Monophasic, polydensified gel resists migration and maintains shape under dynamic movement
- Patient Comfort: Integrated lidocaine minimizes injection pain without additional anesthetics
- Biocompatible & Biodegradable: Microbial-derived HA with minimal endotoxin (< 0.0015 IU/mg) ensures safety and natural resorption
Indications
- Deep to severe wrinkles (nasolabial folds, marionette lines)
- Facial contouring (cheeks, chin, jawline, nose augmentation)
- Lip augmentation and definition
Composition
- Hyaluronic Acid: 24 mg/mL (firm, cross-linked mesh)
- Lidocaine Hydrochloride: 0.3%
- Volume: 1 × 1.1 mL prefilled syringe
Administration
- Needle: 25 G ultra-thin wall (included)
- Injection Depth: Deep dermis to subcutaneous layer
- Technique: Linear threading or small bolus deposits
- Practitioner: Qualified medical professional
Efficacy & Duration
- Onset: Immediate volumization and smoothness
- Duration: 12–18 months, varying by individual metabolism and treatment area
Safety & Precautions
- Single-use only; do not re-sterilize vials
- Avoid mixing with other products or injecting into implant sites
- Contraindicated with quaternary ammonium compounds (e.g., benzalkonium chloride)
- Caution in patients on anticoagulants; avoid NSAIDs, aspirin, high-dose vitamin C one week pre-treatment
- Post-treatment: avoid UV, extreme temperatures and pressure on treated areas for two weeks
- Common, transient reactions: redness, swelling, bruising or tenderness
Storage & Handling
- Store at 2–25 °C; protect from light, heat and freezing
- Shelf life: 24 months from manufacture
Specifications
- Type: Monophasic, polydensified gel
- HA Concentration: 24 mg/mL
- Lidocaine: 0.3%
- Viscosity Index: High (280 Pa·s)
- Packaging: 1.1 mL syringe with 2 × 25 G needles
- Storage: 2–25 °C
